title: Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia.
authors.affiliation: Haemostasis Research Unit, Department of Haematology, University College London, London, UK.
authors.forename: Deepa
authors.initials: D
authors.lastname: Jayakody Arachchillage
authors.forename: Erin
authors.initials: E
authors.lastname: Hurst
authors.forename: Peter
authors.initials: P
authors.lastname: Carey
authors.forename: Samuel
authors.initials: S
authors.lastname: Moses
authors.forename: Stephen G
authors.initials: SG
authors.lastname: O'Brien
authors.forename: Tobias
authors.initials: T
authors.lastname: Menne
authors.forename: Fiona
authors.initials: F
authors.lastname: Keenan
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Wallis
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D051359:Lymphohistiocytosis, Hemophagocytic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine
keywords: chronic lymphocytic leukaemia; fludarabine; haemophagocytic lymphohistiocytosis